Using this application of DXA would, thus, be theoretically advantageous in measuring the effects of subtle changes in body fat composition on insulin resistance and markers of metabolic syndrome such as fasting insulin, blood glucose, cholesterol, triglyceride levels, and blood pressure. This evidence concerns the gene INS and Insulin resistance.